Professor Duncan Jodrell
Professor of Cancer Therapeutics

BM (Southampton) MSc (London) DM (Southampton) FRCP (Edinburgh)

Professional bodies : 

AACR, ACP, Association of Physicians, ASCO, BACR, BMA 

GMC number: 
  • Pancreatic cancer experimental therapeutics 

Duncan was instrumental in establishing the specialist oncology clinic for patients with pancreatic cancer (in 2009), which, together with his research activity in cancer therapeutics were major factors in Cambridge's successful application to become the Regional Centre for Pancreatic Cancer (in 2010). As the Cambridge ECMC Lead for Early Phase Trials, he manages a research team and clinic, allowing patients across the Anglia region to access new therapies for cancer. As a Senior Group Leader in the Cancer Research UK Cambridge Institute, Duncan undertakes research into new therapies for patients with cancer. He also collaborates closely with imaging specialists in both the Institute and Addenbrooke's Hospital, incorporating novel molecular imaging approaches into early phase trials of cancer therapeutics.

Duncan is the Centre Lead for the ECMC Cambridge. For more information on the ECMC Cambridge please visit: